Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors

European Journal of Medicinal Chemistry
2015.0

Abstract

A new class of colchicine derivatives were designed and synthesized as tubulin-HDAC dual inhibitors. Biological evaluations of these hybrids included the inhibitory activity of HDAC, tubulin polymerization analysis, in vitro cell cycle analysis in HCT-116 cells and cytotoxicity against different cancer cell lines. Hybrid 6d behaved as potent HDAC-tubulin dual inhibitor and showed comparable cytotoxicity with colchicine. Compound 11a exhibited powerful tubulin inhibitory activity, moderate anti-HDAC activity and the most potent cytotoxicity (IC50 = 2-105 nM).

Knowledge Graph

Similar Paper

Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
European Journal of Medicinal Chemistry 2015.0
The discovery of colchicine-SAHA hybrids as a new class of antitumor agents
Bioorganic & Medicinal Chemistry 2013.0
Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors
Bioorganic & Medicinal Chemistry Letters 2019.0
Synthesis and biological evaluation of novel anticancer bivalent colchicine–tubulizine hybrids
Bioorganic & Medicinal Chemistry 2012.0
Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation
European Journal of Medicinal Chemistry 2018.0
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors
European Journal of Medicinal Chemistry 2022.0
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4
Journal of Medicinal Chemistry 2018.0
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors
European Journal of Medicinal Chemistry 2021.0
The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase
Bioorganic & Medicinal Chemistry 2013.0
Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives
Bioorganic & Medicinal Chemistry 2021.0